Krotofil M, Tota M, Siednienko J, Donizy P
Cancers (Basel). 2024; 16(20).
PMID: 39456632
PMC: 11506636.
DOI: 10.3390/cancers16203539.
Martinez P, Baghli I, Gourjon G, Seyfried T
Metabolites. 2024; 14(4).
PMID: 38668357
PMC: 11051897.
DOI: 10.3390/metabo14040229.
Bassal M
Biomolecules. 2023; 13(6).
PMID: 37371524
PMC: 10296273.
DOI: 10.3390/biom13060944.
Cao Y
Front Cell Dev Biol. 2023; 11:1092667.
PMID: 37228646
PMC: 10203556.
DOI: 10.3389/fcell.2023.1092667.
Zhu S, Wang J, Zellmer L, Xu N, Liu M, Hu Y
J Cancer. 2022; 13(9):2810-2843.
PMID: 35912015
PMC: 9330459.
DOI: 10.7150/jca.72628.
From Autonomy to Integration, From Integration to Dynamically Balanced Integrated Co-existence: Non-aging as the Third Stage of Development.
Salnikov L, Baramiya M
Front Aging. 2022; 2:655315.
PMID: 35822034
PMC: 9261420.
DOI: 10.3389/fragi.2021.655315.
The Two-Hit Hypothesis Meets Epigenetics.
Issa J
Cancer Res. 2022; 82(7):1167-1169.
PMID: 35373289
PMC: 9872187.
DOI: 10.1158/0008-5472.CAN-22-0405.
Cellular reprogramming to model and study epigenetic alterations in cancer.
Kim J
Stem Cell Res. 2020; 49:102062.
PMID: 33202305
PMC: 7768185.
DOI: 10.1016/j.scr.2020.102062.
Evidence for immortality and autonomy in animal cancer models is often not provided, which causes confusion on key issues of cancer biology.
Dou X, Tong P, Huang H, Zellmer L, He Y, Jia Q
J Cancer. 2020; 11(10):2887-2920.
PMID: 32226506
PMC: 7086263.
DOI: 10.7150/jca.41324.
From cancer to rejuvenation: incomplete regeneration as the missing link (Part I: the same origin, different outcomes).
Baramiya M, Baranov E
Future Sci OA. 2020; 6(3):FSO450.
PMID: 32140249
PMC: 7050604.
DOI: 10.2144/fsoa-2019-0119.
Cancer Etiology: A Metabolic Disease Originating from Life's Major Evolutionary Transition?.
Poljsak B, Kovac V, Dahmane R, Levec T, Starc A
Oxid Med Cell Longev. 2019; 2019:7831952.
PMID: 31687086
PMC: 6800902.
DOI: 10.1155/2019/7831952.
Constructing and Deconstructing Cancers using Human Pluripotent Stem Cells and Organoids.
Smith R, Tabar V
Cell Stem Cell. 2018; 24(1):12-24.
PMID: 30581078
PMC: 6516073.
DOI: 10.1016/j.stem.2018.11.012.
Introduction: Cancer as an Epigenetic Disease.
Issa J
Cancer J. 2017; 23(5):255-256.
PMID: 28926424
PMC: 5708861.
DOI: 10.1097/PPO.0000000000000285.
From Reductionism to Holism: Systems-oriented Approaches in Cancer Research.
Kienle G, Kiene H
Glob Adv Health Med. 2016; 1(5):68-77.
PMID: 27257534
PMC: 4890099.
DOI: 10.7453/gahmj.2012.1.5.015.
DNA repair, genome stability and cancer: a historical perspective.
Jeggo P, Pearl L, Carr A
Nat Rev Cancer. 2015; 16(1):35-42.
PMID: 26667849
DOI: 10.1038/nrc.2015.4.
Cell injury, retrodifferentiation and the cancer treatment paradox.
Uriel J
Tumour Biol. 2015; 36(10):7365-74.
PMID: 26346166
PMC: 4605964.
DOI: 10.1007/s13277-015-3981-2.
Cancer as a mitochondrial metabolic disease.
Seyfried T
Front Cell Dev Biol. 2015; 3:43.
PMID: 26217661
PMC: 4493566.
DOI: 10.3389/fcell.2015.00043.
Control of cancer formation by intrinsic genetic noise and microenvironmental cues.
Brock A, Krause S, Ingber D
Nat Rev Cancer. 2015; 15(8):499-509.
PMID: 26156637
DOI: 10.1038/nrc3959.
Reprogramming of human cancer cells to pluripotency for models of cancer progression.
Kim J, Zaret K
EMBO J. 2015; 34(6):739-47.
PMID: 25712212
PMC: 4369311.
DOI: 10.15252/embj.201490736.
Cancer stem cell theory and the warburg effect, two sides of the same coin?.
Pacini N, Borziani F
Int J Mol Sci. 2014; 15(5):8893-930.
PMID: 24857919
PMC: 4057766.
DOI: 10.3390/ijms15058893.
